Infectious risk of plasma donations: Relationship to safety of intravenous immune globulins

Clinical and Experimental Immunology, Supplement

Volumn 104, Issue SUPPL. 1, 1996, Pages 31-34

  Dodd, R Y ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

Hepatitis C virus; Human immunodeficiency virus; Immunoglobulin; Infection; Intravenous immune globulin; Safety

Indexed keywords

IMMUNOGLOBULIN;

CONFERENCE PAPER; DRUG SAFETY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; RISK; VIRUS INACTIVATION;

BLOOD DONORS; CREUTZFELDT-JAKOB SYNDROME; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PLASMAPHERESIS; RISK FACTORS; VIRUS DISEASES;

EID: 0029990157     PISSN: 09642536     EISSN: None     Source Type: Journal    
DOI: 10.1111/cei.1996.104.s1.31     Document Type: Article

References (25)

1. CDC. Outbreak of hepatitis C associated with intravenous immunoglobulin administration - United States, October 1993-June 1994. Morbidity and Mortality Weekly Report 1994; 43:505-9.
2. McCullough J. The nation's changing blood supply system. J Am Med Assoc 1993; 269:2239-45.
3. Fricke WA, Lamb MA. Viral safety of clotting factor concentrates. Semin Thromb Hemost 1993; 19:54-61.
4. Suomela H. Inactivation of viruses in blood and plasma products. Transf Med Rev 1993; 7:42-57.
5. Ward JW, Holmberg SD, Allen JR et al. Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody. N Engl J Med 1988; 318:473-8.
6. Dodd RY. The risk of transfusion-transmitted infection. N Engl J Med 1992; 327:419-21.
7. Lackritz EM, Satten GA, Kennedy MB et al. Residual risk of transfusion-associated HIV transmission. NIH Consensus Development Conference, Infectious Disease Testing for Blood Transfusions 1995; 21(Abstract).
8. Nelson KE, Donahue JG, Muñoz A et al. Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections. Ann Intern Med 1992; 117:554-9.
9. Busch MP, Eble BE, Khayam-Bashi H et al. Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells. N Engl J Med 1991; 325:1-5.
10. Kleinman S, Secord K. Risk of human immunodeficiency virus (HIV) transmission by anti-HIV negative blood. Estimates using the lookback methodology. Transfusion 1988; 28:499-501.
11. Petersen LR, Satten GA, Dodd R et al. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. Transfusion 1994; 34:283-9.
12. Busch MP, Lee LLL, Satten GA et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: Implications for screening of blood and tissue donors. Transfusion 1995; 35:91-7.
13. Alter MJ. Residual risk of transfusion-associated hepatitis. NIH Consensus Development Conference, Infectious Disease Testing for Blood Transfusions 1995; 23-27. (Abstract).
14. Allander T, Gruber A, Naghavi M et al. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 1995; 345:603-7.
15. Donahue JG, Muñoz A, Ness PM et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327:369-73.
16. Nelson KE, Donahue JG, Stambolis V. Post-transfusion hepatitis C virus infection. Reply. N Engl J Med 1992; 327:1601-2.
17. Kleinman S, Alter H, Busch M et al. Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay. Transfusion 1992; 32:805-13.
18. Holland PV. Why a new standard to prevent Creutzfeldt-Jakob disease. Transfusion 1988; 28:293-4.
19. Weissmann C. Molecular biology of prion diseases. Trends Cell Biol 1994; 4:10-14.
20. Brown P, Gibbs CJ Jr, Amyx HL et al. Chemical disinfection of Creutzfeldt-Jakob disease virus. N Engl J Med 1982; 306:1279-82.
21. Pocchiari M, Peano S, Conz A et al. Combination ultrafiltration and 6 M urea treatment of human growth hormone effectively minimizes risk from potential Creutzfeldt-Jakob disease virus contamination. Horm Res 1991; 35:161-6.
22. Esmonde TFG, Will RG, Slattery JM et al. Creutzfeldt-Jakob disease and blood transfusion. Lancet 1993; 341:205-7.
23. Yap PL. The viral safety of intravenous immune globulin. Clin Exp Immunol 1996; 104, Suppl. 1: 35-42.
24. Biswas RM, Nedjar S, Wilson LT et al. The effect on the safety of intravenous immunoglobulin of testing plasma for antibody to hepatitis C. Transfusion 1994; 34:100-4.
25. Yei S, Yu MW, Tankersley DL. Partitioning of hepatitis C virus during Cohn-Oncley fractionation of plasma. Transfusion 1992; 32:824-8.